Healthcare: Clinical trial inefficiencies and the role of artificial intelligence
Link copied to
On the Bid is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Oriel Morrison discusses the healthcare apps market.
Populating the expert panel this week is Michelle Gallaher, CEO of Opyl (ASX:OPL).
The group discusses a range of topics, including shortcomings in the global clinical trial market, Opyl’s origins and core focus, the company’s launch of Opin, COVID-19 vaccine predictions, AI applications in healthcare sector and more.
So click above to tune in!